Calix (CALX) Financials

$46.98 -0.36 (-0.75%)

Closing price 05/28/2025 03:59 PM Eastern

Extended Trading

$47.24 +0.26 (+0.54%)

As of 05/28/2025 07:44 PM Eastern

Annual Income Statements for Calix

This table shows Calix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-30	29	41	238	33	-18	-19	-83	-27	-26
Consolidated Net Income / (Loss)	-30	29	41	238	33	-18	-19	-83	-27	-26
Net Income / (Loss) Continuing Operations	-30	29	41	238	33	-18	-19	-83	-27	-26
Total Pre-Tax Income	-32	35	54	73	34	-17	-19	-82	-27	-26
Total Operating Income	-43	26	53	74	37	-15	-19	-82	-28	-27
Total Gross Profit	454	518	435	357	267	188	197	173	201	190
Total Revenue	832	1,040	868	679	541	424	441	510	459	407
Operating Revenue	832	1,040	868	679	541	424	441	510	459	407
Total Cost of Revenue	378	521	432	323	274	236	244	337	258	217
Operating Cost of Revenue	378	521	432	323	274	236	244	337	258	217
Total Operating Expenses	497	493	383	283	230	203	216	254	229	217
Selling, General & Admin Expense	99	100	76	56	44	37	41	40	42	38
Marketing Expense	218	215	175	126	94	83	86	83	84	79
Research & Development Expense	180	178	132	102	85	81	90	128	107	90
Total Other Income / (Expense), net	11	9.17	1.43	-1.28	-2.56	-1.13	-0.25	-0.23	1.06	0.71
Interest & Investment Income	12	9.70	2.01	-0.40	-1.59	-0.96	-0.63	-0.16	0.15	0.14
Other Income / (Expense), net	-0.96	-0.53	-0.58	-0.88	-0.98	-0.17	0.38	-0.07	0.91	0.57
Income Tax Expense	-1.90	5.43	13	-166	0.80	1.16	0.53	1.24	0.35	0.54
Basic Earnings per Share	($0.45)	$0.44	$0.63	$3.77	$0.57	($0.32)	($0.37)	($1.66)	($0.56)	($0.51)
Weighted Average Basic Shares Outstanding	65.88M	65.98M	65.06M	63.28M	59.07M	54.99M	52.61M	50.16M	48.73M	51.49M
Diluted Earnings per Share	($0.45)	$0.42	$0.60	$3.51	$0.54	($0.32)	($0.37)	($1.66)	($0.56)	($0.51)
Weighted Average Diluted Shares Outstanding	65.88M	69.32M	68.91M	67.86M	62.00M	54.99M	52.61M	50.16M	48.73M	51.49M
Weighted Average Basic & Diluted Shares Outstanding	66.69M	65.41M	66.14M	64.44M	62.45M	54.99M	52.61M	50.16M	48.73M	51.49M
Cash Dividends to Common per Share	$0.00	$0.00	-	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00

This table shows Calix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/31/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Income / (Loss) Attributable to Common Shareholders	-4.79	-18	-3.97	-7.96	0.10	-6.60	17	9.37	9.60	12	13
Consolidated Net Income / (Loss)	-4.79	-18	-3.97	-7.96	0.10	-6.60	17	9.37	9.60	12	13
Net Income / (Loss) Continuing Operations	-4.79	-18	-3.97	-7.96	0.10	-6.60	17	9.37	9.60	12	13
Total Pre-Tax Income	-2.99	-16	-7.79	-8.68	0.47	-9.02	18	14	11	14	20
Total Operating Income	-6.08	-19	-11	-11	-2.03	-12	16	12	9.94	13	20
Total Gross Profit	123	113	110	108	123	113	141	136	128	125	119
Total Revenue	220	206	201	198	226	265	264	261	250	245	236
Operating Revenue	220	206	201	198	226	265	264	261	250	245	236
Total Cost of Revenue	98	93	91	91	104	151	123	125	122	120	118
Operating Cost of Revenue	98	93	91	91	104	151	123	125	122	120	118
Total Operating Expenses	129	132	121	119	125	125	125	125	118	112	99
Selling, General & Admin Expense	27	27	23	23	26	27	25	25	23	22	19
Marketing Expense	58	59	52	52	54	56	52	55	52	51	46
Research & Development Expense	44	46	45	44	44	42	47	45	43	39	33
Total Other Income / (Expense), net	3.09	3.11	3.10	2.67	2.50	3.07	2.21	2.42	1.47	0.97	0.46
Interest & Investment Income	3.29	3.47	3.28	2.96	2.64	3.15	2.66	2.26	1.64	1.14	0.60
Other Income / (Expense), net	-0.20	-0.36	-0.18	-0.29	-0.14	-0.08	-0.44	0.16	-0.17	-	-0.13
Income Tax Expense	1.80	2.28	-3.82	-0.72	0.37	-2.43	1.19	4.86	1.81	2.16	7.02
Basic Earnings per Share	($0.07)	($0.27)	($0.06)	($0.12)	$0.00	($0.11)	$0.26	$0.14	$0.15	$0.17	$0.21
Weighted Average Basic Shares Outstanding	66.03M	65.88M	66.08M	65.68M	65.34M	65.98M	66.29M	66.27M	66.04M	65.06M	65.36M
Diluted Earnings per Share	($0.07)	($0.27)	($0.06)	($0.12)	$0.00	($0.09)	$0.24	$0.13	$0.14	$0.18	$0.19
Weighted Average Diluted Shares Outstanding	66.03M	65.88M	66.08M	65.68M	68.12M	69.32M	69.58M	69.66M	69.71M	68.91M	69.17M
Weighted Average Basic & Diluted Shares Outstanding	64.82M	66.69M	66.32M	65.80M	65.53M	65.41M	65.87M	66.32M	66.24M	66.14M	65.44M

This table details how cash moves in and out of Calix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-20	-16	28	-29	33	-2.82	10	-11	27	-25
Net Cash From Operating Activities	68	56	27	57	51	4.65	3.56	-63	24	-5.34
Net Cash From Continuing Operating Activities	68	56	27	57	51	4.65	3.56	-63	24	-5.34
Net Income / (Loss) Continuing Operations	-30	29	41	238	33	-18	-19	-83	-27	-26
Consolidated Net Income / (Loss)	-30	29	41	238	33	-18	-19	-83	-27	-26
Depreciation Expense	20	17	14	15	14	10	9.19	11	8.32	10
Amortization Expense	-5.29	-4.20	-1.15	0.00	0.00	-	-	-	6.19	19
Non-Cash Adjustments To Reconcile Net Income	71	63	45	24	18	14	11	13	14	14
Changes in Operating Assets and Liabilities, net	13	-48	-72	-221	-14	-1.79	2.58	-3.38	23	-23
Net Cash From Investing Activities	-110	-6.25	-24	-111	-61	-13	-0.08	20	12	4.67
Net Cash From Continuing Investing Activities	-110	-6.25	-24	-111	-61	-13	-0.08	20	12	4.67
Purchase of Property, Plant & Equipment	-18	-18	-14	-10	-7.82	-13	-10	-8.03	-9.84	-7.28
Purchase of Investments	-302	-216	-191	-298	-73	0.00	0.00	-8.73	-16	-60
Sale and/or Maturity of Investments	210	228	181	198	20	0.00	0.00	36	38	72
Net Cash From Financing Activities	21	-66	25	24	42	5.97	7.49	32	-9.24	-24
Net Cash From Continuing Financing Activities	21	-66	25	24	42	5.97	7.49	32	-9.24	-24
Repurchase of Common Equity	-11	-86	0.00	0.00	-	-	-	-	-13	-27
Other Financing Activities, net	32	20	25	24	12	5.97	0.31	-2.70	-2.08	-1.71
Other Net Changes in Cash	-0.01	-	-	-	-	-	-0.48	-	-	-
Cash Interest Paid	0.00	0.25	0.58	0.63	1.69	1.12	0.65	0.31	0.13	0.13
Cash Income Taxes Paid	5.88	12	9.61	5.20	0.75	0.40	0.56	0.92	0.97	0.48

This table details how cash moves in and out of Calix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/31/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Change in Cash & Equivalents	-0.86	-19	-22	-3.93	25	-72	45	-4.00	15	3.90	24
Net Cash From Operating Activities	17	15	16	22	15	15	16	17	8.11	6.11	6.71
Net Cash From Continuing Operating Activities	17	15	16	22	15	15	16	17	8.11	6.11	6.71
Net Income / (Loss) Continuing Operations	-4.79	-18	-3.97	-7.96	0.10	-6.60	17	9.37	9.60	12	13
Consolidated Net Income / (Loss)	-4.79	-18	-3.97	-7.96	0.10	-6.60	17	9.37	9.60	12	13
Depreciation Expense	4.27	4.75	4.82	5.12	4.87	4.45	4.27	4.19	3.72	3.48	3.17
Amortization Expense	-1.14	-1.33	-1.24	-1.31	-1.41	-1.08	-1.22	-1.19	-0.71	-0.61	-0.53
Non-Cash Adjustments To Reconcile Net Income	20	22	16	15	17	13	16	18	16	13	11
Changes in Operating Assets and Liabilities, net	-0.87	7.80	0.02	11	-5.73	5.47	-20	-13	-21	-22	-20
Net Cash From Investing Activities	11	-34	-49	-30	3.28	-45	57	-15	-3.28	-6.87	10
Net Cash From Continuing Investing Activities	11	-34	-49	-30	3.28	-45	57	-15	-3.28	-6.87	10
Purchase of Property, Plant & Equipment	-4.31	-5.15	-3.24	-5.95	-3.71	-3.97	-3.78	-5.49	-4.62	-4.81	-3.39
Purchase of Investments	-37	-73	-80	-113	-36	-83	-28	-51	-55	-49	-39
Sale and/or Maturity of Investments	52	45	34	89	43	42	89	41	56	47	53
Net Cash From Financing Activities	-29	-0.80	11	4.02	7.08	-43	-28	-6.03	10	4.56	6.61
Net Cash From Continuing Financing Activities	-29	-0.80	11	4.02	7.08	-43	-28	-6.03	10	4.56	6.61
Repurchase of Common Equity	-40	-6.96	-	-	-3.74	-44	-32	-8.82	-1.18	-	-
Other Financing Activities, net	11	6.16	11	4.02	11	1.37	4.90	2.79	11	4.56	6.61
Effect of Exchange Rate Changes	0.07	-	-	-	-	0.16	-	-	0.06	0.10	-0.15

This table presents Calix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	939	942	885	742	427	317	317	295	355	324
Total Current Assets	585	598	547	409	267	144	175	162	219	183
Cash & Equivalents	43	63	79	51	81	47	50	40	50	24
Short-Term Investments	254	157	163	153	53	0.00	-	-	28	50
Accounts Receivable	79	126	94	85	69	47	67	80	51	47
Inventories, net	103	133	149	89	52	40	50	32	45	48
Prepaid Expenses	106	119	63	31	11	9.70	7.31	11	11	9.47
Plant, Property, & Equipment, net	31	29	26	22	20	22	25	16	18	17
Total Noncurrent Assets	323	314	312	311	140	151	117	117	118	124
Goodwill	116	116	116	116	116	116	116	116	116	116
Noncurrent Deferred & Refundable Income Taxes	178	168	167	169	0.00	-	-	-	-	-
Other Noncurrent Operating Assets	30	31	28	26	24	35	1.20	0.76	1.99	1.14
Total Liabilities & Shareholders' Equity	939	942	885	742	427	317	317	295	355	324
Total Liabilities	158	223	205	174	147	163	165	150	143	88
Total Current Liabilities	131	188	165	128	101	115	144	128	121	67
Accounts Payable	20	35	41	29	13	11	40	36	24	20
Accrued Expenses	84	116	90	72	69	58	58	49	70	36
Current Deferred Revenue	27	37	34	27	19	17	16	13	28	12
Total Noncurrent Liabilities	27	35	40	45	46	47	21	22	21	21
Noncurrent Deferred Revenue	21	25	25	22	20	18	17	21	20	20
Other Noncurrent Operating Liabilities	6.30	10	15	23	26	29	3.97	1.13	0.88	1.29
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	781	719	680	568	280	154	152	145	213	236
Total Preferred & Common Equity	781	719	680	568	280	154	152	145	213	236
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	781	719	680	568	280	154	152	145	213	236
Common Stock	1,172	1,080	1,072	999	950	897	878	852	838	820
Retained Earnings	-390	-360	-390	-431	-669	-703	-685	-667	-584	-557
Accumulated Other Comprehensive Income / (Loss)	-0.61	-0.66	-2.47	-0.32	-0.19	-0.85	-0.75	-0.17	-0.66	-0.20

This table presents Calix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	9/28/2024	6/29/2024	3/30/2024	9/30/2023	7/1/2023	4/1/2023	10/1/2022
Total Assets	917	938	918	923	927	942	915	867
Total Current Assets	562	585	570	579	588	599	576	535
Cash & Equivalents	42	62	84	88	136	90	94	75
Short-Term Investments	240	225	177	151	114	174	163	160
Accounts Receivable	76	85	82	100	81	97	92	101
Inventories, net	101	101	113	120	150	153	157	141
Prepaid Expenses	103	112	113	119	107	85	70	59
Plant, Property, & Equipment, net	31	31	31	29	29	29	27	24
Total Noncurrent Assets	324	321	317	315	310	314	311	307
Goodwill	116	116	116	116	116	116	116	116
Noncurrent Deferred & Refundable Income Taxes	179	178	173	170	163	166	168	164
Other Noncurrent Operating Assets	29	27	27	29	31	31	27	27
Total Liabilities & Shareholders' Equity	917	938	918	923	927	942	915	867
Total Liabilities	150	159	164	180	176	200	197	219
Total Current Liabilities	123	130	133	146	139	162	161	181
Accounts Payable	23	24	12	19	22	35	35	66
Accrued Expenses	70	76	89	88	82	85	81	81
Current Deferred Revenue	29	30	32	39	35	42	44	34
Total Noncurrent Liabilities	27	29	31	34	37	38	36	39
Noncurrent Deferred Revenue	21	21	22	24	25	25	25	25
Other Noncurrent Operating Liabilities	5.82	7.55	8.60	9.58	11	12	11	14
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	767	779	754	743	751	742	718	648
Total Preferred & Common Equity	767	779	754	743	751	742	718	648
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	767	779	754	743	751	742	718	648
Common Stock	1,162	1,150	1,123	1,104	1,106	1,114	1,099	1,052
Retained Earnings	-395	-372	-368	-360	-354	-371	-380	-402
Accumulated Other Comprehensive Income / (Loss)	-0.35	0.49	-0.97	-0.98	-1.36	-1.59	-1.31	-3.08

This table displays calculated financial ratios and metrics derived from Calix's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-20.02%	19.79%	27.74%	25.53%	27.55%	-3.85%	-13.53%	11.24%	12.60%	1.55%
EBITDA Growth	-179.30%	-42.51%	-25.96%	77.60%	1,043.08%	41.24%	87.33%	-456.16%	-435.03%	-54.00%
EBIT Growth	-275.58%	-51.85%	-28.78%	103.67%	330.31%	14.13%	77.78%	-200.03%	-4.89%	-28.69%
NOPAT Growth	-239.55%	-45.93%	-83.54%	574.12%	433.80%	16.81%	77.30%	-190.04%	-6.07%	-30.05%
Net Income Growth	-201.44%	-28.49%	-82.80%	611.92%	289.24%	8.31%	76.76%	-203.01%	-4.06%	-26.52%
EPS Growth	-207.14%	-30.00%	-82.91%	550.00%	268.75%	13.51%	77.71%	-196.43%	-9.80%	-24.39%
Operating Cash Flow Growth	21.60%	106.93%	-52.14%	10.47%	1,004.62%	30.73%	105.67%	-357.06%	557.20%	-114.03%
Free Cash Flow Firm Growth	60.87%	-15.85%	-235.16%	-3.79%	265.83%	-66.37%	83.57%	-850.13%	138.02%	-225.88%
Invested Capital Growth	-2.97%	13.88%	20.26%	148.47%	7.30%	3.73%	-2.61%	0.25%	-16.86%	0.98%
Revenue Q/Q Growth	-6.58%	1.98%	8.51%	0.95%	10.14%	1.11%	-4.83%	1.21%	6.20%	-1.60%
EBITDA Q/Q Growth	-30.14%	-40.17%	-4.31%	-10.64%	92.74%	58.29%	39.88%	-1.92%	-109.90%	-63.62%
EBIT Q/Q Growth	-18.70%	-50.61%	-3.95%	-12.82%	186.79%	29.56%	28.42%	-1.22%	-8.28%	-34.76%
NOPAT Q/Q Growth	-18.31%	-48.54%	-19.12%	-1.13%	190.19%	30.15%	29.12%	-0.65%	-9.76%	-35.06%
Net Income Q/Q Growth	-61.48%	-38.72%	-16.24%	-1.74%	238.94%	25.56%	27.41%	-1.69%	-7.61%	-33.16%
EPS Q/Q Growth	-66.67%	-39.13%	-15.49%	-3.31%	285.71%	27.27%	28.85%	-1.84%	-7.69%	-37.84%
Operating Cash Flow Q/Q Growth	0.65%	18.59%	-19.33%	-23.92%	138.49%	96.04%	112.31%	-563.13%	2,097.93%	-123.91%
Free Cash Flow Firm Q/Q Growth	2.40%	14.54%	-101.90%	-39.73%	1,553.10%	41.14%	68.27%	-529.98%	161.57%	-603.32%
Invested Capital Q/Q Growth	-1.48%	-0.44%	6.01%	4.95%	2.41%	3.26%	8.77%	23.35%	-14.22%	-0.31%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.55%	49.86%	50.17%	52.49%	49.33%	44.29%	44.73%	33.88%	43.86%	46.74%
EBITDA Margin	-3.57%	3.61%	7.51%	12.96%	9.16%	-1.24%	-2.03%	-13.84%	-2.77%	0.93%
Operating Margin	-5.18%	2.46%	6.06%	10.88%	6.81%	-3.63%	-4.20%	-15.98%	-6.13%	-6.51%
EBIT Margin	-5.29%	2.41%	6.00%	10.75%	6.63%	-3.67%	-4.11%	-15.99%	-5.93%	-6.37%
Profit (Net Income) Margin	-3.58%	2.82%	4.73%	35.09%	6.19%	-4.17%	-4.37%	-16.27%	-5.97%	-6.46%
Tax Burden Percent	94.00%	84.37%	75.89%	328.10%	97.67%	107.03%	102.82%	101.52%	101.28%	102.07%
Interest Burden Percent	71.94%	138.73%	103.86%	99.45%	95.58%	106.15%	103.48%	100.20%	99.44%	99.46%
Effective Tax Rate	0.00%	15.63%	24.11%	-228.10%	2.33%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-6.13%	4.61%	9.96%	95.02%	25.42%	-8.04%	-9.71%	-42.28%	-13.25%	-11.50%
ROIC Less NNEP Spread (ROIC-NNEP)	-6.28%	1.26%	9.47%	97.51%	28.73%	28.61%	32.47%	16.76%	-3.08%	-3.12%
Return on Net Nonoperating Assets (RNNOA)	2.17%	-0.42%	-3.38%	-38.85%	-10.00%	-3.53%	-3.29%	-4.11%	1.04%	1.14%
Return on Equity (ROE)	-3.97%	4.19%	6.57%	56.17%	15.42%	-11.57%	-13.00%	-46.40%	-12.21%	-10.36%
Cash Return on Invested Capital (CROIC)	-3.12%	-8.37%	-8.44%	9.81%	18.38%	-11.70%	-7.07%	-42.53%	5.15%	-12.47%
Operating Return on Assets (OROA)	-4.68%	2.74%	6.40%	12.49%	9.64%	-4.91%	-5.93%	-25.10%	-8.01%	-7.47%
Return on Assets (ROA)	-3.16%	3.21%	5.04%	40.77%	9.00%	-5.58%	-6.31%	-25.53%	-8.07%	-7.59%
Return on Common Equity (ROCE)	-3.97%	4.19%	6.57%	56.17%	15.42%	-11.57%	-13.00%	-46.40%	-12.21%	-10.36%
Return on Equity Simple (ROE_SIMPLE)	-3.81%	4.08%	6.03%	41.94%	11.94%	-11.49%	-12.70%	-57.28%	-12.87%	-11.17%
Net Operating Profit after Tax (NOPAT)	-30	22	40	243	36	-11	-13	-57	-20	-19
NOPAT Margin	-3.62%	2.08%	4.60%	35.71%	6.65%	-2.54%	-2.94%	-11.19%	-4.29%	-4.55%
Net Nonoperating Expense Percent (NNEP)	0.15%	3.35%	0.49%	-2.49%	-3.31%	-36.65%	-42.19%	-59.04%	-10.18%	-8.38%
Return On Investment Capital (ROIC_SIMPLE)	-3.86%	3.00%	5.87%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	45.45%	50.14%	49.83%	47.51%	50.67%	55.71%	55.27%	66.12%	56.14%	53.26%
SG&A Expenses to Revenue	11.89%	9.66%	8.79%	8.21%	8.21%	8.75%	9.18%	7.81%	9.07%	9.44%
R&D to Revenue	21.63%	17.10%	15.21%	14.98%	15.75%	19.13%	20.39%	24.99%	23.29%	22.02%
Operating Expenses to Revenue	59.73%	47.40%	44.11%	41.60%	42.53%	47.92%	48.92%	49.86%	49.99%	53.24%
Earnings before Interest and Taxes (EBIT)	-44	25	52	73	36	-16	-18	-82	-27	-26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-30	37	65	88	50	-5.26	-8.95	-71	-13	3.79
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.96	4.00	6.59	8.97	6.56	2.88	3.41	2.07	1.76	1.70
Price to Tangible Book Value (P/TBV)	3.48	4.77	7.95	11.27	11.20	11.73	14.49	10.42	3.88	3.54
Price to Revenue (P/Rev)	2.78	2.77	5.16	7.50	3.40	1.05	1.17	0.59	0.82	0.98
Price to Earnings (P/E)	0.00	98.13	109.20	21.39	54.90	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	1.02%	0.92%	4.68%	1.82%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	4.17	5.33	9.68	13.44	11.63	3.12	3.78	2.15	2.21	2.01
Enterprise Value to Revenue (EV/Rev)	2.42	2.56	4.88	7.20	3.15	1.01	1.13	0.57	0.65	0.80
Enterprise Value to EBITDA (EV/EBITDA)	0.00	70.89	64.97	55.57	34.38	0.00	0.00	0.00	0.00	86.07
Enterprise Value to EBIT (EV/EBIT)	0.00	106.07	81.42	66.99	47.52	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	123.10	106.11	20.17	47.37	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	29.46	47.24	155.85	86.18	33.16	91.63	139.82	0.00	12.19	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	195.51	65.51	0.00	0.00	0.00	38.87	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.19	0.20	0.21	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.35	-0.33	-0.36	-0.40	-0.35	-0.12	-0.10	-0.25	-0.34	-0.37
Leverage Ratio	1.25	1.31	1.30	1.38	1.71	2.07	2.06	1.82	1.51	1.37
Compound Leverage Factor	0.90	1.81	1.35	1.37	1.64	2.20	2.13	1.82	1.51	1.36
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	16.30%	16.49%	17.15%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	16.30%	16.49%	17.15%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	83.70%	83.51%	82.85%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-5.71	-3.35	-0.42	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	3.32	2.27	0.14	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-2.78	-2.31	-0.53	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	1.62	1.56	0.17	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	9.49	8.93	14.17	18.50	7.32	-0.18	0.18	-1.01	0.65	1.74
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.46	3.19	3.31	3.19	2.64	1.25	1.22	1.27	1.81	2.72
Quick Ratio	2.87	1.85	2.03	2.26	2.01	0.81	0.81	0.94	1.07	1.80
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-15	-39	-34	25	26	-16	-9.43	-57	7.65	-20
Operating Cash Flow to CapEx	378.86%	315.04%	193.24%	542.80%	657.49%	34.85%	34.15%	-782.11%	248.19%	-73.39%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.88	1.14	1.07	1.16	1.45	1.34	1.44	1.57	1.35	1.17
Accounts Receivable Turnover	8.10	9.46	9.70	8.79	9.34	7.47	5.99	7.75	9.32	10.46
Inventory Turnover	3.21	3.70	3.63	4.57	5.93	5.24	5.97	8.87	5.59	4.60
Fixed Asset Turnover	27.44	37.60	36.45	32.23	25.83	18.26	21.73	30.32	26.12	21.85
Accounts Payable Turnover	13.75	13.69	12.27	15.31	22.94	9.27	6.40	11.29	11.86	10.04
Days Sales Outstanding (DSO)	45.07	38.59	37.65	41.54	39.09	48.83	60.96	47.10	39.18	34.89
Days Inventory Outstanding (DIO)	113.83	98.78	100.47	79.80	61.51	69.71	61.11	41.14	65.34	79.40
Days Payable Outstanding (DPO)	26.55	26.66	29.74	23.84	15.91	39.37	57.00	32.34	30.77	36.35
Cash Conversion Cycle (CCC)	132.35	110.71	108.37	97.49	84.69	79.17	65.07	55.90	73.74	77.93
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	484	499	438	364	147	137	132	135	135	162
Invested Capital Turnover	1.69	2.22	2.16	2.66	3.82	3.16	3.31	3.78	3.09	2.52
Increase / (Decrease) in Invested Capital	-15	61	74	218	9.97	4.91	-3.53	0.33	-27	1.58
Enterprise Value (EV)	2,015	2,657	4,236	4,894	1,705	426	498	290	298	326
Market Capitalization	2,312	2,878	4,478	5,099	1,838	444	518	300	376	400
Book Value per Share	$11.78	$10.92	$10.38	$8.92	$4.54	$2.78	$2.86	$2.88	$4.37	$4.64
Tangible Book Value per Share	$10.02	$9.15	$8.61	$7.09	$2.66	$0.68	$0.67	$0.57	$1.98	$2.22
Total Capital	781	719	680	568	280	184	182	175	213	236
Total Debt	0.00	0.00	0.00	0.00	0.00	30	30	30	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-297	-220	-242	-204	-134	-17	-20	-9.78	-78	-74
Capital Expenditures (CapEx)	18	18	14	10	7.82	13	10	8.03	9.84	7.28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	157	190	140	77	32	11	11	24	20	42
Debt-free Net Working Capital (DFNWC)	454	410	382	281	166	58	61	64	98	116
Net Working Capital (NWC)	454	410	382	281	166	28	31	34	98	116
Net Nonoperating Expense (NNE)	-0.38	-7.74	-1.09	4.21	2.50	6.91	6.34	26	7.72	7.78
Net Nonoperating Obligations (NNO)	-297	-220	-242	-204	-134	-17	-20	-9.78	-78	-74
Total Depreciation and Amortization (D&A)	14	12	13	15	14	10	9.19	11	15	30
Debt-free, Cash-free Net Working Capital to Revenue	18.82%	18.27%	16.16%	11.30%	5.92%	2.56%	2.45%	4.77%	4.32%	10.30%
Debt-free Net Working Capital to Revenue	54.55%	39.47%	44.01%	41.38%	30.64%	13.75%	13.84%	12.56%	21.34%	28.36%
Net Working Capital to Revenue	54.55%	39.47%	44.01%	41.38%	30.64%	6.68%	7.04%	6.69%	21.34%	28.36%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.45)	$0.44	$0.63	$3.77	$0.57	($0.32)	($0.37)	($1.66)	($0.56)	($0.51)
Adjusted Weighted Average Basic Shares Outstanding	65.88M	65.98M	65.06M	63.28M	59.07M	56.56M	54.04M	51.71M	49.59M	48.45M
Adjusted Diluted Earnings per Share	($0.45)	$0.42	$0.60	$3.51	$0.54	($0.32)	($0.37)	($1.66)	($0.56)	($0.51)
Adjusted Weighted Average Diluted Shares Outstanding	65.88M	69.32M	68.91M	67.86M	62.00M	56.56M	54.04M	51.71M	49.59M	48.45M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	($0.32)	($0.37)	($1.66)	($0.56)	($0.51)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.69M	65.41M	66.14M	64.44M	62.45M	54.99M	52.61M	50.16M	48.73M	51.49M
Normalized Net Operating Profit after Tax (NOPAT)	-30	22	40	51	42	-11	-14	-54	-23	-19
Normalized NOPAT Margin	-3.62%	2.08%	4.60%	7.54%	7.78%	-2.54%	-3.10%	-10.60%	-4.98%	-4.55%
Pre Tax Income Margin	-3.81%	3.34%	6.23%	10.69%	6.33%	-3.90%	-4.25%	-16.03%	-5.90%	-6.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-35.95%	294.62%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-46.74%	-103.21%

This table displays calculated financial ratios and metrics derived from Calix's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/31/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.68%	-22.14%	-23.84%	-24.09%	-9.48%	8.27%	11.64%	29.19%	35.18%	38.59%	37.22%
EBITDA Growth	-343.43%	-78.18%	-140.47%	-152.29%	-89.88%	-155.32%	-17.66%	13.83%	-7.34%	-9.13%	6.44%
EBIT Growth	-189.66%	-56.93%	-171.51%	-197.23%	-122.18%	-193.29%	-22.07%	26.99%	-0.85%	-5.80%	13.37%
NOPAT Growth	-851.83%	-55.07%	-151.24%	-202.17%	-105.35%	-176.60%	13.27%	3.11%	2.61%	-47.59%	-92.82%
Net Income Growth	-4,747.57%	-171.62%	-123.41%	-184.90%	-98.93%	-155.33%	26.11%	24.62%	18.22%	-40.01%	-92.42%
EPS Growth	0.00%	-200.00%	-125.00%	-192.31%	-100.00%	-150.00%	26.32%	18.18%	16.67%	-37.93%	-92.72%
Operating Cash Flow Growth	17.16%	2.94%	1.57%	27.96%	81.10%	144.46%	134.60%	149.52%	10.14%	-51.62%	-37.94%
Free Cash Flow Firm Growth	132.89%	102.40%	102.91%	69.97%	41.87%	-10.43%	-37.65%	63.88%	64.17%	68.08%	-154.48%
Invested Capital Growth	-3.65%	-2.97%	-1.95%	3.22%	9.21%	13.88%	21.26%	21.77%	21.68%	20.26%	19.06%
Revenue Q/Q Growth	6.85%	2.58%	1.42%	-12.45%	-14.51%	0.34%	1.08%	4.40%	2.25%	3.46%	16.97%
EBITDA Q/Q Growth	79.92%	-109.21%	4.24%	-705.18%	114.70%	-147.52%	23.72%	17.15%	-19.68%	-29.27%	71.04%
EBIT Q/Q Growth	67.15%	-72.53%	4.88%	-437.24%	82.20%	-178.62%	29.32%	22.57%	-25.15%	-34.32%	110.74%
NOPAT Q/Q Growth	67.57%	-72.08%	4.05%	-1,677.49%	94.72%	-156.86%	91.31%	-6.92%	-24.35%	-15.91%	74.14%
Net Income Q/Q Growth	73.29%	-351.71%	50.14%	-7,826.21%	101.56%	-138.93%	80.87%	-2.34%	-19.53%	-11.28%	78.74%
EPS Q/Q Growth	74.07%	-350.00%	50.00%	0.00%	100.00%	-137.50%	84.62%	-7.14%	-22.22%	-5.26%	72.73%
Operating Cash Flow Q/Q Growth	12.04%	-3.98%	-28.41%	52.11%	-1.56%	-5.25%	-9.81%	115.29%	32.87%	-9.07%	-4.07%
Free Cash Flow Firm Q/Q Growth	748.27%	-21.67%	109.10%	45.62%	38.09%	5.05%	6.04%	-5.24%	-17.61%	-18.36%	75.35%
Invested Capital Q/Q Growth	0.21%	-1.48%	-0.39%	-2.03%	0.92%	-0.44%	4.86%	3.66%	5.24%	6.01%	5.30%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.72%	55.00%	54.76%	54.31%	54.16%	42.78%	53.27%	52.28%	51.22%	51.08%	50.17%
EBITDA Margin	-1.43%	-7.61%	-3.73%	-3.95%	0.57%	-3.33%	7.02%	5.74%	5.11%	6.51%	9.52%
Operating Margin	-2.76%	-9.10%	-5.42%	-5.73%	-0.90%	-4.57%	6.04%	4.53%	3.97%	5.34%	8.46%
EBIT Margin	-2.85%	-9.27%	-5.51%	-5.88%	-0.96%	-4.60%	5.87%	4.59%	3.91%	5.34%	8.41%
Profit (Net Income) Margin	-2.17%	-8.70%	-1.97%	-4.02%	0.05%	-2.49%	6.43%	3.59%	3.84%	4.88%	5.69%
Tax Burden Percent	160.10%	114.60%	50.92%	91.66%	22.01%	73.13%	93.44%	65.87%	84.13%	84.67%	65.68%
Interest Burden Percent	47.63%	81.86%	70.36%	74.57%	-21.60%	74.12%	117.17%	118.83%	116.79%	107.94%	102.99%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	77.99%	0.00%	6.56%	34.13%	15.87%	15.33%	34.32%
Return on Invested Capital (ROIC)	-3.23%	-10.78%	-6.81%	-7.88%	-0.42%	-7.10%	12.59%	6.80%	7.43%	9.78%	11.70%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.03%	-8.92%	-8.17%	-7.87%	-0.64%	-7.91%	11.73%	6.15%	6.90%	9.39%	11.56%
Return on Net Nonoperating Assets (RNNOA)	1.05%	3.08%	2.87%	2.77%	0.22%	2.61%	-4.07%	-2.21%	-2.48%	-3.36%	-4.14%
Return on Equity (ROE)	-2.18%	-7.70%	-3.94%	-5.11%	-0.20%	-4.49%	8.52%	4.59%	4.95%	6.43%	7.57%
Cash Return on Invested Capital (CROIC)	-2.96%	-3.12%	-3.17%	-8.60%	-6.45%	-8.37%	-10.04%	-10.35%	-9.97%	-8.44%	-4.41%
Operating Return on Assets (OROA)	-2.56%	-8.19%	-5.26%	-6.02%	-1.06%	-5.23%	6.67%	5.25%	4.31%	5.69%	8.61%
Return on Assets (ROA)	-1.95%	-7.69%	-1.89%	-4.12%	0.05%	-2.84%	7.30%	4.11%	4.24%	5.20%	5.82%
Return on Common Equity (ROCE)	-2.18%	-7.70%	-3.94%	-5.11%	-0.20%	-4.49%	8.52%	4.59%	4.95%	6.43%	7.57%
Return on Equity Simple (ROE_SIMPLE)	-4.51%	0.00%	-2.37%	0.33%	2.67%	0.00%	6.37%	5.98%	5.92%	0.00%	7.56%
Net Operating Profit after Tax (NOPAT)	-4.26	-13	-7.63	-7.95	-0.45	-8.46	15	7.78	8.36	11	13
NOPAT Margin	-1.93%	-6.37%	-3.80%	-4.01%	-0.20%	-3.20%	5.64%	2.98%	3.34%	4.52%	5.56%
Net Nonoperating Expense Percent (NNEP)	-0.20%	-1.85%	1.36%	0.00%	0.22%	0.81%	0.85%	0.65%	0.53%	0.39%	0.14%
Return On Investment Capital (ROIC_SIMPLE)	-0.55%	-1.68%	-	-	-	-1.18%	-	-	-	1.63%	-
Cost of Revenue to Revenue	44.28%	45.00%	45.24%	45.69%	45.84%	57.22%	46.73%	47.72%	48.78%	48.92%	49.83%
SG&A Expenses to Revenue	12.15%	13.01%	11.53%	11.41%	11.62%	10.31%	9.59%	9.47%	9.23%	9.04%	8.14%
R&D to Revenue	19.97%	22.25%	22.63%	22.27%	19.63%	15.98%	17.80%	17.37%	17.27%	15.77%	14.05%
Operating Expenses to Revenue	58.48%	64.10%	60.19%	60.04%	55.06%	47.34%	47.23%	47.76%	47.24%	45.74%	41.71%
Earnings before Interest and Taxes (EBIT)	-6.28	-19	-11	-12	-2.17	-12	15	12	9.77	13	20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.15	-16	-7.50	-7.83	1.29	-8.81	19	15	13	16	23
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.05	2.96	3.25	3.08	2.94	4.00	4.05	4.46	4.94	6.59	6.16
Price to Tangible Book Value (P/TBV)	3.59	3.48	3.82	3.64	3.49	4.77	4.79	5.29	5.89	7.95	7.50
Price to Revenue (P/Rev)	2.83	2.78	2.84	2.44	2.15	2.77	2.98	3.33	3.80	5.16	4.99
Price to Earnings (P/E)	0.00	0.00	0.00	928.99	110.14	98.13	63.53	74.56	83.42	109.20	81.46
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.11%	0.91%	1.02%	1.57%	1.34%	1.20%	0.92%	1.23%
Enterprise Value to Invested Capital (EV/IC)	4.24	4.17	4.57	4.18	3.86	5.33	5.57	6.37	7.13	9.68	9.09
Enterprise Value to Revenue (EV/Rev)	2.49	2.42	2.52	2.16	1.91	2.56	2.74	3.07	3.52	4.88	4.69
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	646.48	74.81	70.89	44.53	45.87	50.63	64.97	55.09
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	148.26	106.07	55.00	55.51	62.39	81.42	69.30
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	171.52	123.10	66.51	75.35	81.68	106.11	76.05
Enterprise Value to Operating Cash Flow (EV/OCF)	28.97	29.46	33.01	30.43	30.95	47.24	58.82	79.23	117.70	155.85	111.41
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.35	-0.35	-0.35	-0.35	-0.34	-0.33	-0.35	-0.36	-0.36	-0.36	-0.36
Leverage Ratio	1.22	1.25	1.22	1.24	1.26	1.31	1.28	1.28	1.29	1.30	1.32
Compound Leverage Factor	0.58	1.03	0.86	0.93	-0.27	0.97	1.50	1.52	1.51	1.41	1.36
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	10.20	9.58	10.50	9.52	8.39	8.80	11.58	11.02	11.81	14.02	11.76
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.58	4.46	4.50	4.28	3.96	3.19	4.22	3.69	3.58	3.31	2.96
Quick Ratio	2.91	2.87	2.87	2.58	2.33	1.85	2.38	2.22	2.17	2.03	1.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	14	1.66	2.12	-23	-43	-69	-73	-78	-74	-63	-53
Operating Cash Flow to CapEx	399.35%	298.37%	493.19%	375.45%	396.09%	375.73%	417.13%	318.16%	175.66%	127.00%	197.82%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.90	0.88	0.96	1.02	1.11	1.14	1.14	1.14	1.10	1.07	1.02
Accounts Receivable Turnover	9.39	8.10	10.73	10.65	10.55	9.46	11.25	10.83	10.36	9.70	8.31
Inventory Turnover	3.37	3.21	3.48	3.52	3.64	3.70	3.36	3.84	3.53	3.63	3.68
Fixed Asset Turnover	27.65	27.44	29.56	31.82	36.09	37.60	38.13	39.00	37.52	36.45	35.30
Accounts Payable Turnover	17.49	13.75	18.80	19.94	18.49	13.69	11.08	16.60	12.65	12.27	8.16
Days Sales Outstanding (DSO)	38.87	45.07	34.02	34.29	34.58	38.59	32.44	33.69	35.24	37.65	43.92
Days Inventory Outstanding (DIO)	108.31	113.83	104.76	103.84	100.24	98.78	108.57	94.94	103.49	100.47	99.18
Days Payable Outstanding (DPO)	20.86	26.55	19.41	18.31	19.74	26.66	32.96	21.99	28.86	29.74	44.75
Cash Conversion Cycle (CCC)	126.32	132.35	119.36	119.82	115.08	110.71	108.05	106.64	109.88	108.37	98.35
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	485	484	491	493	503	499	501	478	461	438	413
Invested Capital Turnover	1.67	1.69	1.79	1.96	2.11	2.22	2.23	2.28	2.22	2.16	2.10
Increase / (Decrease) in Invested Capital	-18	-15	-9.75	15	42	61	88	85	82	74	66
Enterprise Value (EV)	2,054	2,015	2,243	2,060	1,945	2,657	2,790	3,042	3,287	4,236	3,754
Market Capitalization	2,337	2,312	2,531	2,322	2,184	2,878	3,040	3,306	3,544	4,478	3,989
Book Value per Share	$11.50	$11.78	$11.83	$11.51	$11.37	$10.92	$11.32	$11.20	$10.85	$10.38	$9.93
Tangible Book Value per Share	$9.76	$10.02	$10.07	$9.74	$9.59	$9.15	$9.57	$9.44	$9.10	$8.61	$8.15
Total Capital	767	781	779	754	743	719	751	742	718	680	648
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-282	-297	-288	-261	-239	-220	-250	-264	-257	-242	-235
Capital Expenditures (CapEx)	4.31	5.15	3.24	5.95	3.71	3.97	3.78	5.49	4.62	4.81	3.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)	157	157	168	176	193	190	198	173	158	140	120
Debt-free Net Working Capital (DFNWC)	439	454	455	437	433	410	448	437	415	382	355
Net Working Capital (NWC)	439	454	455	437	433	410	448	437	415	382	355
Net Nonoperating Expense (NNE)	0.53	4.80	-3.66	0.01	-0.55	-1.86	-2.07	-1.59	-1.24	-0.88	-0.30
Net Nonoperating Obligations (NNO)	-282	-297	-288	-261	-239	-220	-250	-264	-257	-242	-235
Total Depreciation and Amortization (D&A)	3.13	3.42	3.58	3.81	3.46	3.37	3.04	3.00	3.02	2.87	2.63
Debt-free, Cash-free Net Working Capital to Revenue	19.00%	18.82%	18.82%	18.45%	19.02%	18.27%	19.46%	17.41%	16.97%	16.16%	15.00%
Debt-free Net Working Capital to Revenue	53.20%	54.55%	51.13%	45.86%	42.59%	39.47%	44.00%	44.04%	44.52%	44.01%	44.35%
Net Working Capital to Revenue	53.20%	54.55%	51.13%	45.86%	42.59%	39.47%	44.00%	44.04%	44.52%	44.01%	44.35%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.07)	($0.27)	($0.06)	($0.12)	$0.00	($0.11)	$0.26	$0.14	$0.15	$0.17	$0.21
Adjusted Weighted Average Basic Shares Outstanding	66.03M	65.88M	66.08M	65.68M	65.34M	65.98M	66.29M	66.27M	66.04M	65.06M	65.36M
Adjusted Diluted Earnings per Share	($0.07)	($0.27)	($0.06)	($0.12)	$0.00	($0.09)	$0.24	$0.13	$0.14	$0.18	$0.19
Adjusted Weighted Average Diluted Shares Outstanding	66.03M	65.88M	66.08M	65.68M	68.12M	69.32M	69.58M	69.66M	69.71M	68.91M	69.17M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	64.82M	66.69M	66.32M	65.80M	65.53M	65.41M	65.87M	66.32M	66.24M	66.14M	65.44M
Normalized Net Operating Profit after Tax (NOPAT)	-4.26	-13	-7.63	-7.95	-1.42	-8.46	15	7.78	8.36	11	13
Normalized NOPAT Margin	-1.93%	-6.37%	-3.80%	-4.01%	-0.63%	-3.20%	5.64%	2.98%	3.34%	4.52%	5.56%
Pre Tax Income Margin	-1.36%	-7.59%	-3.88%	-4.38%	0.21%	-3.41%	6.88%	5.45%	4.56%	5.76%	8.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-135.49%	-35.95%	-259.07%	3,206.68%	448.57%	294.62%	88.63%	22.55%	2.78%	0.00%	0.00%

Frequently Asked Questions About Calix's Financials

When does Calix's financial year end?

According to the most recent income statement we have on file, Calix's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Calix's net income changed over the last 9 years?

Calix's net income appears to be on an upward trend, with a most recent value of -$29.75 million in 2024, rising from -$26.33 million in 2015. The previous period was $29.33 million in 2023. See Calix's forecast for analyst expectations on what’s next for the company.

What is Calix's operating income?

Calix's total operating income in 2024 was -$43.03 million, based on the following breakdown:

Total Gross Profit: $453.59 million
Total Operating Expenses: $496.63 million

How has Calix revenue changed over the last 9 years?

Over the last 9 years, Calix's total revenue changed from $407.46 million in 2015 to $831.52 million in 2024, a change of 104.1%.

How much debt does Calix have?

Calix's total liabilities were at $158.33 million at the end of 2024, a 29.0% decrease from 2023, and a 79.7% increase since 2015.

How much cash does Calix have?

In the past 9 years, Calix's cash and equivalents has ranged from $23.63 million in 2015 to $80.81 million in 2020, and is currently $43.16 million as of their latest financial filing in 2024.

How has Calix's book value per share changed over the last 9 years?

Over the last 9 years, Calix's book value per share changed from 4.64 in 2015 to 11.78 in 2024, a change of 153.8%.

Related Companies

This page (NYSE:CALX) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Calix (CALX) Financials

Frequently Asked Questions About Calix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Calix (CALX) Financials

Annual Income Statements for Calix

Quarterly Income Statements for Calix

Annual Cash Flow Statements for Calix

Quarterly Cash Flow Statements for Calix

Annual Balance Sheets for Calix

Quarterly Balance Sheets for Calix

Annual Metrics And Ratios for Calix

Quarterly Metrics And Ratios for Calix

Frequently Asked Questions About Calix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools